Pfizer to create omicron-specific COVID-19 vaccine

Pfizer and BioNTech are researching an omicron-specific COVID-19 vaccine after studies show that the latest coronavirus variant is able to evade vaccines quite well. Jennifer Pancorbo, a vaccine manufacturing expert with North Carolina State University, lays out how quickly we could modify COVID-19 vaccines.